Skip to content 
That fact is important to state clearly.
Available treatments can help manage symptoms.
Medications can be highly beneficial for many patients.
Exercise and rehabilitation strategies can also play important roles in care.
Deep brain stimulation can help selected patients manage certain motor symptoms.
Treatment plans are individualized because Parkinson’s does not affect everyone in exactly the same way.
Researchers continue investigating therapies designed not merely to control symptoms but potentially to slow, stop or prevent disease progression.
Those approaches remain areas of active research.
Fox and his Foundation have consistently emphasized the goal of eventually eliminating Parkinson’s.
But hope for a future cure is different from claiming that one currently exists.
That distinction is essential.
The Scale of Parkinson’s Has Also Become Clearer
Parkinson’s is not a rare challenge affecting only a handful of families.
A 2026 report released by The Michael J. Fox Foundation estimated that approximately 1.2 million people in the United States were living with Parkinson’s disease and related conditions.
The same report estimated the economic impact of Parkinson’s disease and atypical parkinsonisms in the United States at $82.2 billion in 2024.
Those costs include more than medical bills.
They include caregiving.
They include reduced work and productivity.
They include disability-related costs.
They affect patients.
They affect families.
And they affect public health systems.
The numbers explain why Parkinson’s research is not simply about one famous actor.
Fox may have helped bring unprecedented visibility to the disease.
But the research mission extends far beyond him.
Changing How Parkinson’s Is Discussed
When Fox publicly disclosed his diagnosis in 1998, celebrity discussions of chronic neurological disease were less common than they are today.